890 results on '"Kivipelto, M"'
Search Results
152. THE ROAD AHEAD TO CURE ALZHEIMER\'S DISEASE: DEVELOPMENT OF BIOLOGICAL MARKERS AND NEUROIMAGING METHODS FOR PREVENTION TRIALS ACROSS ALL STAGES AND TARGET POPULATIONS
153. The influence of multimorbidity on clinical progression of dementia in a population-based cohort
154. Differences in brain cholesterol metabolism and insulin in two subgroups of patients with different CSF biomarkers but similar white matter lesions suggest different pathogenic mechanisms
155. Serum total cholesterol, statins and cognition in non-demented elderly
156. Metabolome in progression to Alzheimer's disease
157. Lipid-lowering treatment is related to decreased risk of dementia : a population-based study (FINRISK)
158. Depressive signs in midlife : A risk factor for cognitive impairment in later life?
159. Homocysteine and holo-transcobalamin and the risk of dementia and Alzheimers disease : a prospective study.
160. Serum total cholesterol, statins and cognition in non-demented elderly
161. Plasma levels of 24S-hydroxycholesterol reflect brain volumes in patients without objective cognitive impairment but not in those with Alzheimer's disease
162. A multi-metabolite analysis of serum by H-1 NMR spectroscopy: Early systemic signs of Alzheimer's disease
163. BDNF is a novel marker of cognitive function in ageing women: the DR's EXTRA Study
164. Incidence of stroke in people with Alzheimer disease: A national register-based approach
165. Serum cholesterol changes after midlife and late-life cognition : Twenty-one-year follow-up study
166. Dementia Prevention: A Global Challenge in Urgent Need of Solutions.
167. Midlife income, occupation, APOE status, and dementia: a population-based study.
168. Are the CSF levels of 24S-hydroxycholesterol a sensitive biomarker for mild cognitive impairment?
169. Midlife vascular risk factors and late-life mild cognitive impairment: A population-based study.
170. Mild cognitive impairment associates with concurrent decreases in serum cholesterol and cholesterol-related lipoprotein subclasses
171. Differences in brain cholesterol metabolism and insulin in two subgroups of patients with different CSF biomarkers but similar white matter lesions suggest different pathogenic mechanisms
172. Associations between serum homocysteine, holotranscobalamin, folate and cognition in the elderly: a longitudinal study
173. Metabolome in progression to Alzheimer's disease
174. World's most prolific researcher in Alzheimer's disease: Professor Bengt Winblad
175. Homocysteine and holotranscobalamin and the risk of Alzheimer disease: A longitudinal study
176. Exercise, fitness and cognition – A randomised controlled trial in older individuals: The DR's EXTRA study
177. Diabetes, Alzheimer disease, and vascular dementia
178. S.23.01 Risk factors for Alzheimer's disease
179. Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease
180. Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis
181. Midlife Smoking, Apolipoprotein E and Risk of Dementia and Alzheimer’s Disease: A Population-Based Cardiovascular Risk Factors, Aging and Dementia Study
182. Lipid-Lowering Treatment Is Related to Decreased Risk of Dementia: A Population-Based Study (FINRISK)
183. FACTORS ASSOCIATED WITH RESISTANCE TO DEMENTIA DESPITE HIGH ALZHEIMER DISEASE PATHOLOGY
184. Glucose tolerance and cognitive function in men and women: DR'S extra study (ISRCTN45977199)
185. Lifestyle related factors in stroke and dementia
186. Epidemiology of cholesterol and lipids: Risk and protective factors for AD and VaD
187. Risk factor versus risk marker: Serum total cholesterol, its changes after midlife and late-life cognitive impairment
188. Association between mid-life marital status and cognitive function in later life: population based cohort study
189. Preventive neurology: On the way from knowledge to action
190. EDUCATION AND DEMENTIA: WHAT LIES BEHIND THE ASSOCIATION?
191. Total cholesterol and the risk of Parkinson disease
192. Apolipoprotein E ε4 Allele Is Associated with Increased Atrophy in Progressive Mild Cognitive Impairment: A Voxel-Based Morphometric Study
193. Alzheimer’s disease — The ways of prevention
194. Education and dementia
195. Serum high sensitivity C-reactive protein and cognitive function in elderly women
196. Serum cholesterol changes after midlife and late-life cognition
197. Body mass index and the risk of Parkinson disease
198. Fat Intake at Midlife and Risk of Dementia and Alzheimer’s Disease: A Population-Based Study
199. Apolipoprotein E, B Vitamins, and Cognitive Function in Older Adults
200. Decreased brain creatine levels in elderly apolipoprotein E ?4 carriers
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.